Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

Read on to learn more about the signs of psoriasis on your feet and how it can be treated. Plaque psoriasis is the most common type of psoriasis. It makes up about 90% of cases. It’s also known ...

The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...